Vanguard Capital Wealth Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 1730578 DENVER, CO

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$239,414

-$24,274 QoQ

Shares Held

1,895

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,809

of 2,266 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Vanguard Capital Wealth Advisors holds $3,241,473 across 6 Drug Manufacturers - General names. GILD ranks #6 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	3,858	$970,827
2	LLY	ELI LILLY & Co	735	$881,581
3	BMY	Bristol Myers Squibb Co	9,127	$525,897
4	NVS	Novartis AG	2,050	$321,276
5	JNJ	Johnson & Johnson	1,191	$302,478
6	GILD	Gilead Sciences, Inc. This page	1,895	$239,414

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$239,414	1,895	+0.2%	Shares	Sole	2026-07-23
2026-03-31	$263,688	1,892	+0.2%	Shares	Sole	2026-04-21
2025-12-31	$231,855	1,889	+0.2%	Shares	Sole	2026-01-16
2025-09-30	$209,346	1,886	+0.2%	Shares	Sole	2025-10-30
2025-06-30	$208,768	1,883	+0.2%	Shares	Sole	2025-07-11
2025-03-31	$210,541	1,879	-43.3%	Shares	Sole	2025-04-11
2021-06-30	$228,133	3,313	-62.7%	Shares	Sole	2021-07-28
2021-03-31	$573,655	8,876	+129.8%	Shares	Sole	2021-04-12
2020-06-30	$297,142	3,862	—	Shares	Sole	2020-08-05
No filing history on record for this holder in this stock.